Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic proliferation with variable clinical behavior caused by the accumulation of CD1a + /CD207 + histiocytes, associated with a variable number of eosinophils, lymphocytes, plasma cells and multinucleated giant cells, most commonly observed in male children. LCH is uncommon in the head and neck region, occurring as ulcerated and reddened plaques or nodules that cause destruction of adjacent soft tissues and bone. The exact etiology of LCH is still unknown and controversial, with possible etiologic role of viruses, including Epstein-Barr virus (EBV). The aim of this study was to describe the clinicopathologic and immunohistochemical features of patients with LCH of the head and neck region. Clinical data from 19 patients with LCH were obtained from the archives of the Federal University of Rio de Janeiro and the Clinical Head and Neck Center of Guatemala. All cases were submitted to morphological, immunohistochemical analysis with CD1a, CD207, CD3, CD20, CD68, S-100 and Ki-67 and in situ hybridization for EBV. Ten cases were female and 9 male, with mean age of 11.5 years. Fourteen cases were located in the oral cavity, three cases in lymph nodes, and two cases in the scalp. In regard to the oral lesions, 13 cases were intra-osseous with six cases in anterior mandible, five cases in posterior mandible, and two cases in posterior maxilla while one case was located exclusively in the gingiva. The inflammatory pattern showed variation in the number of plasma cells, eosinophils and lymphocytes, while tumor cells were positive for CD1a, S-100 and CD68 in all cases, and positive for CD207 in 18 cases. In situ hybridization for EBV were negative in all cases.
Introduction
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic proliferation with variable clinical behavior caused by the accumulation of CD1a + /CD207 + histiocytes in an inflammatory background [1] [2] [3] [4] . It is most common in children from 1 to 3 years and the clinical presentation depends on the extension and location of the lesions, and therefore treatment may vary from conservative curettage for patients with single-bone lesions, to chemotherapy for patients with disseminated involvement of liver, bone marrow and/or spleen [4, 5] . LCH may affect the head and neck, particularly the oral and maxillofacial region, where is usually identified as an ill-defined unilocular radiolucency with tooth displacement or premature tooth loss [6] [7] [8] . Oral soft tissue lesions appear as a painful reddish swelling or ulcer in the gingiva and hard palate, which may be accompanied by enlargement of the lymph nodes, diabetes insipidus, skin lesions, and hepatomegaly [7, 9] . The diagnosis of LCH depends on the microscopic identification of histiocytes with abundant eosinophilic cytoplasm and lobulated or coffee bean-like nucleus containing delicate chromatin and inconspicuous nucleoli admixed with variable number of eosinophils, lymphocytes, neutrophils, plasma cells and multinucleated giant cells associated with immunohistochemical study [1, 10] . The histiocytes are consistently positive for CD1a and CD207, an immunophenotype shared by normal epidermal Langerhans cells [11] . Recent studies indicate the origin of LCH as a misguided differentiation of myeloid dendritic cell precursors through activation of ERK signaling pathway [4] . However, the exact etiology of LCH is still unknown and controversial, with possible etiologic roles of viruses, including Epstein-Barr virus (EBV) [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
To the best of our knowledge there are only a few case series of head and neck LCH [22] [23] [24] [25] [26] [27] , most of them from developed countries, with limited immunohistochemical findings (Table 1) . Thus, the aim of this study is to describe the clinicopathological features of 19 patients with LCH of the head and neck region from Latin America with emphasis on the oral cavity, including immunohistochemical findings and in situ hybridization for EBV.
Materials and Methods
Nineteen Langerhans cell histiocytosis' patients with involvement of the head and neck region were retrieved from the files of 3 Latin American pathology diagnostic services for this retrospective cross-sectional study from 1984 to 2017 (13 cases from Federal University of Rio de Janeiro, Brazil [8 cases from oral pathology laboratory of School of Dentistry and 5 cases from pathology laboratory of School of Medicine], and 6 cases from Centro Clínico de Cabeza y Cuello, Guatemala City, Guatemala). Demographic, clinical, and radiological data were obtained from the laboratories' records. All cases were analyzed under light microscopy using 3 μm sections on histologic slides stained with hematoxylin-eosin (HE). This study was carried out following the Helsinki Declaration For detection of Epstein-Barr virus's RNA, PNA Probe/ Fluorescein probe (code Y5200, Dako ® ) and PNA/ISH Detection Kit (code k5201, Dako ® ) were used for histological sections of tissue microarray (TMA), according to the manufacturer instructions. The EBER signal has to be detected in the nucleus of the tumor cells, which has to be dark brown, using the DAKO kit.
Results

Clinical Data
The clinical data of 19 cases of LCH are summarized in Table 2 . Ten patients were female and 9 were male. The mean age was 11.5 years, ranging from one month to 51 years. Fourteen cases (73.6%) were located in the oral cavity, three cases (15.7%) in lymph nodes, and two cases (10.5%) in the scalp. Oral lesions were mainly intra-osseous (13 cases [92.8%]-six cases in anterior mandible, five cases in posterior mandible, and two cases in posterior maxilla) while one case was located exclusively in the gingiva (Figs. 1, 2) . Ten cases were unifocal lesions and nine cases presented as multifocal lesions. Eight patients (42%) had pain and the size of lesions ranged from 0.3 to 4 cm. The main extra-oral clinical findings were facial swelling (4 cases) and cervical lymphadenopathy (4 cases). The most common intra-oral findings were ill-defined unilocular radiolucency (8 cases) with gingival involvement (7 cases) and tooth mobility (7 cases), followed by ulcerated lesion (4 cases), cortical bone expansion/destruction (2 cases), nodular lesion (1 case), and plaque lesion (1 case). Four cases had systemic disease, with the first clinical manifestation as cutaneous lesions followed by visceral compromise (gastrointestinal tract, liver, spleen, thymus or lymph nodes). Information about treatment was obtained in 5 cases. All patients received treatment with vinblastine and steroids according to Histiocyte Society's LCH-III (3 cases) and LCH-II (2 cases). Two patients showed recurrence and two patients died.
Immunohistochemical Findings
The histopathological and immunohistochemical features of 19 cases of LCH are summarized in Tables 2 and 3 . All cases exhibited the characteristic histiocytic cell of the LCH, which were positive for S-100, CD68, CD1a, and CD207, with one negative case for CD207 (Figs. 3, 4) . The inflammatory reaction was heterogeneous with a large variation in the number of plasma cells, eosinophils and lymphocytes. Epithelial surface was present in 8 cases whereas 10 cases showed dense connective tissue and 4 cases showed loose connective tissue. Necrosis was present in 5 cases (27.8%), multinucleated giant cells in 4 cases (22.2%), atypical mitotic figures in 4 cases (22.2%), bacterial colonies in 3 cases (16.7%), and apoptotic bodies in 3 cases (16.7%). Four cases (21%) showed Ki-67 proliferation index lower than 20%, 13 cases (68.4%) between 21 and 40%, and two cases (10.5%) between 41 and 50%. In situ hybridization for EBV was negative in all the cases studied.
Discussion
Langerhans cell histiocytosis (LCH) is the most common type of histiocytosis affecting children, with involvement of the head and neck region in up to 90% of cases, particularly the skull and jaws. The peak age range is between 1 and 4 years old, and patients with focal lesions are generally [30] . In the present study, 74% of the patients were children, and the mean age of patients with multisystemic disease was 1.7 years. Despite the male predilection of LCH patients in the literature, our study showed no difference between genders [10, 28, [31] [32] [33] [34] . Considering LCH involving the oral cavity, most patients are younger than 40 years of age, with a mean age of about 19 years [2] . Unifocal single system disease represents about 50% of oral LCH, with multifocal single system disease and multifocal multisystem disease equally distributed in the remaining 50% of cases, as also observed in our cases [2, 35] . The jaws are involved twice as frequently as the oral soft tissues. The mandible is preferentially affected over the maxilla, particularly the posterior regions [30] [31] [32] [33] [34] [35] . Gingiva and hard palate are common oral soft tissues affected by LCH, as painful or bleeding ulcerated nodules [2] . In our study, six cases were located in anterior mandible, five cases in posterior mandible, and two cases in posterior maxilla, while one case was located exclusively in the gingiva. Jaw lesions tend to present as unilocular radiolucencies with well-demarcated or poorly defined borders, which may involve adjacent teeth with consequent dental displacement, dental pain and mobility with "floating teeth" appearance, findings also observed in seven of our cases [2-28, 30-32, 35] . Cutaneous involvement of LCH may present as an early manifestation of disseminated disease [36] [37] [38] [39] [40] [41] [42] , as observed in four cases of the present study. One patient was born with skin lesions on the scalp and chest, but the disease progressed and reached the liver, spleen and thymus, leading to death of the patient 1 year after treatment [36] [37] [38] [39] [40] [41] [42] . The involvement of cervical lymph nodes appears either in Fig. 3 Microscopical features of Langerhans cell histiocytosis of the head and neck: many oval to round LCH cells with abundant cytoplasm and twisted or lobulated nucleus containing delicate chromatin and inconspicuous nucleoli, resembling "coffee bean", is observed admixed with eosinophils and lymphocytes (HE, ×400) the isolated form or as part of a multisystemic disease [43] . In our study, two cases exhibited only cervical lymph node involvement, and one case was part of the multisystem disease. The thymus plays an important role in the development of the immune system and is composed of dendritic cells, but its involvement in LCH is rare. Thymus involvement is observed in younger patients with multisystem disease and a higher mortality rate [44, 45] . In our study, a 1-month-old boy presented aggressive and systemic form of LCH with involvement of the thymus and progression to death.
In the morphological analysis, we observed a great heterogeneity of the inflammatory reaction, with no differences between proportions of T lymphocytes (CD3) and B lymphocytes (CD20), variable proportion of eosinophils, and small quantity of plasma cells in most cases. Multinucleated giant cells were observed only in four cases of the present study, two cases in the oral cavity and two cases in cervical lymph nodes. Necrosis, apoptosis and atypical mitotic figures, often found in malignant neoplasms, were observed in 17, 22, and 28% respectively. Necrosis was mainly observed in cases with high proliferative index. The Ki-67 antigen is expressed during several phases of the cell cycle (i.e., G1, S, G2, and M) and can be correlated with mitotic counts and aggressiveness of disease [46, 47] . In our study, patients with systemic disease had Ki-67 higher than 40%, and still showed foci of necrosis in the histopathological analysis.
In correlation with clinical and morphological features, CD1a antigen expression provides the basis for the diagnosis of LCH in most instances [10] . However, CD1a expression is not specific for LCH, since it may also observed in other histiocytic proliferations such as juvenile xanthogranuloma, sinus histiocytosis with massive lymphadenopathy, and histiocytic sarcoma [48] . Langerin (CD207) is a relatively new immunohistochemical marker that may serve as a surrogate indicator for the presence of Birbeck granules in LCH histiocytes [48] . When directly compared with CD1a in the present study, expression of Langerin exhibited similar sensitivity, but slightly lower specificity, since one case was negative. Therefore, CD207 immunoreactivity seems to be a reliable alternative to CD1a antigen expression as evidence for a definitive diagnosis of LCH.
The etiology of LCH is widely discussed, but today it is known that Langerhans cell histiocytosis is a disease caused by somatic driver mutations at critical stages of myeloid differentiation that result in cellular transformation [4] . Mutations in the MAPK pathway have been identified in approximately 75% of patients with LCH. Additionally, immunohistochemical studies were able to identify the expression of the common BRAFV600E mutation in CD207 + [49, 50] . An important implication of the new understanding of LCH biology, suggesting a new definition as an inflammatory myeloid neoplasia [4] . A series of studies, have reported the association of Epstein-Barr virus (EBV) infection with several malignancies and LCH, representing a possible etiologic role or contribution to its pathophysiology [12] [13] [14] [15] [16] [17] . Our study was conducted in two Latin American countries, where EBV infection is very prevalent. We decided to evaluate it by two methodologies (IHQ and HIS), and all cases were negative for EBV, as also showed by McClain et al. in 56 LCH cases [19] . Therefore, the evidence of EBV as an etiologic factor for LCH is weak and its expression could be just coincidental in some cases, which was not observed in these Latin American patients.
Currently, investigation into LCH treatment is continuing with the Histiocyte Society's ongoing LCH-III trial. LCH-I and LCH-II have been completed and demonstrated the effectiveness of chemotherapy with vinblastine and steroids, and now LCH-III is prospectively studying treatment of high risk patients with methotrexate or 6-mercaptopurine and adjusting treatment length and intensity based on response [9, 51, 52] . Also, intralesional steroid injections have been proposed for the bone lesions and radiation was proposed by some authors but should be given only in lowdoses (6-10 Gy) to reduce the risk of secondary tumors. This treatment is considered suitable for individual clinical use if treatment is important to conserve function and if intralesional therapy is not feasible. In relation to prognosis, the two main poor prognostic factors are the involvement of a high-risk-organ (liver, spleen, lung and bone marrow) and the lack of efficacy of the treatment [9, 51, 52] .
In summary, this is the first case series of LCH of the head and neck in a Latin American population, with immunohistochemical findings. LCH is uncommon in the head and neck region, mainly presenting as unifocal or multifocal disease in the posterior regions of the mandible of young patients, which may present gingival bleeding and premature loss of teeth. The identification of lymphoplasmacytic infiltrate with predominance of eosinophils and histiocytes positive for CD1a and CD207 is required to confirm the diagnosis of LCH.
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